Dec 21 (Reuters) - NOVACYT SA ALNOV.PA :
* NOVACYT S.A. ("NOVACYT", THE "COMPANY" OR THE "GROUP"): COVID-19 DIAGNOSTIC TESTS REMAIN ABLE TO DETECT ALL PUBLISHED VIRUS STRAINS
* HAS CARRIED OUT A DETAILED ANALYSIS OF MUTATIONS IN THIS NEW VARIANT AND IN ALL PUBLISHED COVID-19 STRAINS TO FULLY ASSESS RELIABILITY OF ITS EXISTING DIAGNOSTIC TESTS